An epidemiologist who has speculated about whether there is a connection between Covid-19 vaccines and “turbo cancer” in young people, and works as chief epidemiologist at a company that sells ivermectin alongside reviews that claim it has efficacy as a cancer treatment, has been appointed by president Donald Trump to a key position overseeing the National Cancer Program.
Harvey Risch, a professor emeritus of epidemiology at the Yale School of Public Health, announced his appointment as chair of the President’s Cancer Panel on X earlier this month. Risch’s profile page on the
→ Continue reading at Wired - Science